Literature DB >> 9506990

Human ZFM1 protein is a transcriptional repressor that interacts with the transcription activation domain of stage-specific activator protein.

D Zhang1, G Childs.   

Abstract

Stage-specific activator protein (SSAP) is the transcription factor responsible for the activation of the sea urchin late H1 gene at the mid-blastula stage of embryogenesis. SSAP contains an extremely potent transcription activation domain that functions 4-5-fold better than VP16 in a variety of mammalian cell lines. We used the two-hybrid screening technique to identify human cDNAs from an HL60 cell-derived cDNA library that encode proteins that interact with the transcription activation domain of SSAP. One of these cDNAs encodes ZFM1, a protein previously identified at the locus linked to multiple endocrine neoplasia type 1 (MEN1) and as presplicing factor SF1. Functional assays establish the ZFM1 protein as a transcriptional repressor. ZFM1 protein represses Gal4-GQC-mediated transcription, and this activity requires both a repression domain found in the N-terminal 137 amino acids of the protein, as well as a GQC interaction region. The physiological significance of repression mediated by ZFM1 comes from the ability of its specific repression domain to function when fused to Gal4 and tethered to promoters containing Gal4 binding sites. The activity is unique in that activated but not basal transcription levels are affected.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9506990     DOI: 10.1074/jbc.273.12.6868

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  The transcription elongation factor CA150 interacts with RNA polymerase II and the pre-mRNA splicing factor SF1.

Authors:  A C Goldstrohm; T R Albrecht; C Suñé; M T Bedford; M A Garcia-Blanco
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

Review 2.  A subset of nuclear receptor coregulators act as coupling proteins during synthesis and maturation of RNA transcripts.

Authors:  Didier Auboeuf; Dennis H Dowhan; Martin Dutertre; Natalia Martin; Susan M Berget; Bert W O'Malley
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

3.  An artificial transcriptional activating region with unusual properties.

Authors:  X Lu; A Z Ansari; M Ptashne
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-29       Impact factor: 11.205

4.  SF1 Phosphorylation Enhances Specific Binding to U2AF65 and Reduces Binding to 3'-Splice-Site RNA.

Authors:  Rakesh Chatrikhi; Wenhua Wang; Ankit Gupta; Sarah Loerch; Alexandre Maucuer; Clara L Kielkopf
Journal:  Biophys J       Date:  2016-12-20       Impact factor: 4.033

5.  Temporal activation of the sea urchin late H1 gene requires stage-specific phosphorylation of the embryonic transcription factor SSAP.

Authors:  Z Li; G Childs
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

6.  Major phosphorylation of SF1 on adjacent Ser-Pro motifs enhances interaction with U2AF65.

Authors:  Valérie Manceau; Matthew Swenson; Jean-Pierre Le Caer; André Sobel; Clara L Kielkopf; Alexandre Maucuer
Journal:  FEBS J       Date:  2006-02       Impact factor: 5.542

7.  Transient interaction of BBP/ScSF1 and Mud2 with the splicing machinery affects the kinetics of spliceosome assembly.

Authors:  B Rutz; B Séraphin
Journal:  RNA       Date:  1999-06       Impact factor: 4.942

8.  Splicing factor SF1 from Drosophila and Caenorhabditis: presence of an N-terminal RS domain and requirement for viability.

Authors:  R Mazroui; A Puoti; A Krämer
Journal:  RNA       Date:  1999-12       Impact factor: 4.942

9.  Human splicing factor SF3a, but not SF1, is essential for pre-mRNA splicing in vivo.

Authors:  Goranka Tanackovic; Angela Krämer
Journal:  Mol Biol Cell       Date:  2005-01-12       Impact factor: 4.138

Review 10.  Alternative splicing in aging and longevity.

Authors:  Malini Bhadra; Porsha Howell; Sneha Dutta; Caroline Heintz; William B Mair
Journal:  Hum Genet       Date:  2019-12-13       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.